By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Venn Therapeutics 



Mason  Ohio  45040  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

At Venn Therapeutics, we are focused on developing novel, first-in-class drugs that polarize tumor-resident innate immune cells to an anti-tumor phenotype and reverse the immunosuppressive microenvironment found within tumors. Powering the immune system is our focus and we welcome the opportunity to work with other companies to advance innovative cancer therapies from research labs to patient bedside. Our approach has been to form collaborations with academic researchers in order to fund the development and clinical validation of novel immunotherapies.

YEAR FOUNDED:

2015

LEADERSHIP:

CEO: Sam Shrivastava

PIPELINE:

Please click here for ImmunoMet Therapeutics' pipeline.


Key Statistics


Email:
Ownership: Private

Web Site: Venn Therapeutics
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->